FDA Panel: Split Decision for Descovy in PrEP

– Solid yes for men and transgender women, but consensus missing for cisgender women An FDA advisory panel overwhelmingly voted 16-2 to recommend Descovy, the fixed-dose combination of emtricitabine and tenofovir alafenamide (F/TAF), as pre-exposure prophylaxis...

Henry House – One Woman’s Journey

By Bri Silva & Julie Dowling, Co-Facilitators of This is Us, a support group for women living with or affected by HIV Henry House is the place she went to die. It was a place that many, over the years, would also go to die in order to spare those they loved the...

The Spahr Center lobbies for PrEP and PEP

Andy Fyne, Testing & Prevention Manager PrEP and PEP are exciting and important strategies for helping us to prevent new HIV infections.  But both medically-based prevention strategies are suffering from alarmingly low levels of use.  The Spahr Center is engaging...

PrEP Could Become Over-the-Counter Drug In California

A bill just approved by the California State Senate would make Truvada, the HIV drug that’s been found to be effective at preventing new HIV infections, available for over-the-counter use for 30 days. The bill is aimed at HIV-negative gay and bisexual men of...